Tel: 972-2-6758725    

 Join us | Contact | Giving  
  • Facebook
  • Twitter
  • LinkedIn
מרכז לאוטנברג לאימונולוגיה וחקר הסרטן  | Lautenberg Center for Immunology and Cancer research
  • Home
  • The Lautenberg center
    • About the center
    • Donors and friends of the center
    • Senator Lautenberg
    • Rabbi Shai Shacknai award
    • James Sivarsten Award
    • Annual retreats
    • Events gallery
    • The annual progress report
    • Safety
  • People
    • Faculty
    • Emeritus Faculty
    • Management & administrative staff
    • Hall of fame
    • Alumni members and students
  • Seminars
  • Facilities
  • Home
  • The Lautenberg center
    • About the center
    • Donors and friends of the center
    • Senator Lautenberg
    • Rabbi Shai Shacknai award
    • James Sivarsten Award
    • Annual retreats
    • Events gallery
    • The annual progress report
    • Safety
  • People
    • Faculty
    • Emeritus Faculty
    • Management & administrative staff
    • Hall of fame
    • Alumni members and students
  • Seminars
  • Facilities
PoC-ERC grant to Prof. Aqeilan
Home » PoC-ERC grant to Prof. Aqeilan

PoC-ERC grant to Prof. Aqeilan

The Aqeilan’s laboratory won the prestigious proof-of-concept ERC (PoC-ERC) grant to develop a cure for WOREE syndrome.

 Prof. Rami Aqeilan is among 55 scientists who received €8.25 in #ERCPoC grants. The proposed study, WWOXAID, focuses on WWOX-related epileptic encephalopathy (WOREE) syndrome, also known as early infantile epileptic encephalopathy, 28 (EIEE28, OMIM: 616211). WOREE is a very severe epileptic encephalopathy characterized by absence of language development and acquisition of walking, early-onset drug-resistant seizures, ophthalmological involvement, and a very high likelihood of premature death. Above all, WWOXAID aims to set the basis for bringing into clinical development a treatment for WOREE syndrome affecting children in infancy. This development is critical because there is no current treatment that could save children with WOREE. In addition to this highly humanitarian purpose, Prof. Aqeilan is confident that this PoC achievement shall be also of importance for broadening the spectrum of applications of this treatment in other WWOX-related disorders.

To Prof. Aqeilan’s lab page >>

The Concern Foundation Laboratories at the Lautenberg center for immunology and cancer research

Israel-Canada Medical Research Institute
Faculty of Medicine, The Hebrew University
POB 12272, Jerusalem 91120, Israel
Tel: 972-2-6757725;
Fax: 972-2-6430834;

Design by toornet
Scroll to top
Skip to content
Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset